您的位置: 首页 > 2020年11月 第51卷 第6期 > 文字全文
2023年7月 第38卷 第7期11
目录

细胞毒素-1对人卵巢癌细胞体外增殖、凋亡的影响

Effect of cytotoxin-1 on human ovarian cancer cell proliferation and apoptosis in vitro

来源期刊: 广州医药 | 24-27 发布时间:2021-11-28 收稿时间:2025/11/13 17:39:24 阅读量:42
作者:
关键词:
细胞毒素-1人卵巢癌SKOV-3 细胞增殖凋亡
Cytotoxin-1Human ovarian cancer SKOV-3 cellsProliferationApoptosis
DOI:
10.3969/j.issn.1000-8535.2020.06.005
收稿时间:
2020-05-07 
修订日期:
 
接收日期:
 
引用总数:
0  
目的 探讨细胞毒素-1(Cytotoxin-1,CTX-1)对人卵巢癌SKOV-3细胞增殖凋亡的影响。方法 利用0、4、8、12 μg/mL浓度 CTX-1处理SKOV-3细胞6、12、24 h,MTS法检测细胞活性,8 μg/mL CTX-1处理SKOV-3细胞24、48 h,Hoechst-33258荧光染色观察细胞核染色质形态。取处理 6、12 h 后细胞,利用流式细胞仪检测SKOV-3细胞的凋亡率。结果 4、8、12 μg/mL的CTX-1可抑制SKOV-3细胞活性及增殖,呈时间-剂量依赖。Hoechst-33258染色观察可见细胞染色质呈固缩或碎裂状、染色质着色不均、核形态各异,随时间增加而更趋明显。8 μg/mL CTX-1处理细胞,6 h细胞坏死率为(1.90±0. 27)%,晚期凋亡率为(10.96±1. 56)%,而早期凋亡率为(1.52±0.39)%;12 h细胞坏死率为(10.62±0.96)%,晚期凋亡率(15.07±1.23)%,而早期凋亡率为(1.88±0.17)%,与对照组比较,差异有统计学意义 (P<0.0 1)。结论 CTX-1可以抑制人卵巢癌细胞活性、抑制其体外增殖、诱导其发生凋亡,该作用呈剂量依赖和时间依赖,主要引起细胞晚期凋亡和坏死。
Objective To investigate the effect of cytotoxin-1 (CTX-1)on the proliferation and apoptosis of ovarian cancer SKOV-3 cells. Methods SKOV-3 cells were treated with CTX-1 at concentrations of 0, 4, 8, 12 μg/mL for 6, 12, and 24 hours respectively. Cell viability was measured by MTS method. SKOV-3 cells were treated with 8 μg/mL CTX-1 for 24 and 48 hours, by Hoechst-33258 fluorescence staining to observe the morphology of nuclear chromatin. The apoptotic rate of SKOV-3 cells was detected by flow cytometry after 6 and 12 hours of treatment. Results CTX-1 at 4, 8, and 12 μg/mL inhibited the activity and proliferation of SKOV-3 cells in a time-dose-dependent manner. Hoechst-33258 staining observation showed that the apoptotic cell chromatin was condensed or fragmented chromatin, the chromatin was unevenly colored, and the nuclear morphology was different. It became more obvious with time. 8 μg/mL CTX-1 treated cells, the 6 h cell necrosis rate was (1.90±0.27)%, the late apoptosis rate was (10.96±1.56)%, and the early apoptosis rate was (1.52±0.39)%; 12 hours cell necrosis rate was (10.62±0.96)%, late apoptosis rate was (15.07±1.23)%, and early apoptosis rate was (1.88±0.17)%, compared with the control group, the difference was statistically significant (P<0.01). Conclusion CTX-1 may inhibit the activity of human ovarian cancer cells, inhibit its proliferation in vitro, and induce its apoptosis. The effect is dose-dependent and time-dependent. Mainly it causes late apoptosis and necrosis of cells.
1、 CHIENCM,YANGSH, YANG C C, et al.CardiotoxinIIIinducesc-junN-terminalkinase-dependentapoptosisin HL-60human leukaemia cells[J].Cell Bionchem Funct,2008,26(1): 111-118. CHIENCM,YANGSH, YANG C C, et al.CardiotoxinIIIinducesc-junN-terminalkinase-dependentapoptosisin HL-60human leukaemia cells[J].Cell Bionchem Funct,2008,26(1): 111-118.
2、HINMAN C L, TANG H P. A membrane lytic immunoconjugate selective for human tumor T lymphocytes [J]. Int J Immunopha, 1998(20): 467-468.HINMAN C L, TANG H P. A membrane lytic immunoconjugate selective for human tumor T lymphocytes [J]. Int J Immunopha, 1998(20): 467-468.
3、 WU M, MING W,TANG Y, et al. The anticancer effect of cytotoxin 1 from naja atra cantor venom is mediated by a lysosomal cell death pathway involving lysosomal membrane permeabilization and cathepsin B release[J].Am J Chin Med,2013,41(3):643-663. WU M, MING W,TANG Y, et al. The anticancer effect of cytotoxin 1 from naja atra cantor venom is mediated by a lysosomal cell death pathway involving lysosomal membrane permeabilization and cathepsin B release[J].Am J Chin Med,2013,41(3):643-663.
4、 雷丹青, 王秋雁, 刘绵林, 等. 广西眼镜蛇毒细胞毒素的分离及对人鼻咽癌等细胞抑制作用的研究[J].中国药理学通报, 2002(18): 61-64. 雷丹青, 王秋雁, 刘绵林, 等. 广西眼镜蛇毒细胞毒素的分离及对人鼻咽癌等细胞抑制作用的研究[J].中国药理学通报, 2002(18): 61-64.
5、 PINATO D J, GRAHAM J, GABRA H, et al. Evolving concepts in the management of drugresistant ovarian cancer: Dose dense chemotherapy and the reversal of clinical platinum resistance[J]. Cancer Treat Rev, 2013, 39(2): 153-160. PINATO D J, GRAHAM J, GABRA H, et al. Evolving concepts in the management of drugresistant ovarian cancer: Dose dense chemotherapy and the reversal of clinical platinum resistance[J]. Cancer Treat Rev, 2013, 39(2): 153-160.
6、BOGUSH T A, POPOVA A S, DUDKO E A, et al. ERCC1 as a marker of ovarian cancer resistanceto platinum drugs[J]. Antibiot Khimioter, 2015, 60(3-4): 42-50.BOGUSH T A, POPOVA A S, DUDKO E A, et al. ERCC1 as a marker of ovarian cancer resistanceto platinum drugs[J]. Antibiot Khimioter, 2015, 60(3-4): 42-50.
7、 COPUR M S, GAUCHAN D, RAMAEKERS R, et al. Neoadjuvant chemotherapy or primary debulking surgery for stage iiic ovarian cancer[J]. J Clin Oncol, 2017, 35(7):802-803. COPUR M S, GAUCHAN D, RAMAEKERS R, et al. Neoadjuvant chemotherapy or primary debulking surgery for stage iiic ovarian cancer[J]. J Clin Oncol, 2017, 35(7):802-803.
8、 吴敏燕, 孔天翰,唐娅,等. 舟山眼镜蛇细胞毒素1对K562细胞的抑制作用[J].中国病理生理杂志,2011, 27(7): 1297-1301. 吴敏燕, 孔天翰,唐娅,等. 舟山眼镜蛇细胞毒素1对K562细胞的抑制作用[J].中国病理生理杂志,2011, 27(7): 1297-1301.
9、 TSAI P C, CHU C L, CHIU C C, et al. Inhibition of Src activation with cardiotoxin III blocks migration and invasion of MDA-MB-231 cells[J].Toxicon, 2013,(74):56-67. TSAI P C, CHU C L, CHIU C C, et al. Inhibition of Src activation with cardiotoxin III blocks migration and invasion of MDA-MB-231 cells[J].Toxicon, 2013,(74):56-67.
10、 FEOFANOV A V, SHARONOV G V, ASTAPOVA M V, et al. Cancer cell injury by cytotoxins from cobravenom is mediated though lysosomal damage[J].Biochem J, 2005, 390(1):11-18. FEOFANOV A V, SHARONOV G V, ASTAPOVA M V, et al. Cancer cell injury by cytotoxins from cobravenom is mediated though lysosomal damage[J].Biochem J, 2005, 390(1):11-18.
11、 SAMUEL P, MULCAHY L A, FURLONG F, et al. Cisplatin induces the release of extracellular vesicles from ovarian cancer cells that can induce invasiveness and drug resistance in bystander cells[J].Philos Trans R Soc Lond B Biol Sci,2018,373(1737): 20170065. SAMUEL P, MULCAHY L A, FURLONG F, et al. Cisplatin induces the release of extracellular vesicles from ovarian cancer cells that can induce invasiveness and drug resistance in bystander cells[J].Philos Trans R Soc Lond B Biol Sci,2018,373(1737): 20170065.
12、 FERLAY J, SOERJOMATARAM I, DIKSHIT R, et al. Cancer incidence and mortality worldwide: sources, Methods and major patterns in GLOBOCAN 2012[J].Int J Cancer, 2015, 136(5): 359-386. FERLAY J, SOERJOMATARAM I, DIKSHIT R, et al. Cancer incidence and mortality worldwide: sources, Methods and major patterns in GLOBOCAN 2012[J].Int J Cancer, 2015, 136(5): 359-386.
13、 JAYSON G C, KOHN E C, KITCHENER H C, et al. Ovarian cancer[J]. Lancet,2014,384(9951):1376-1388. JAYSON G C, KOHN E C, KITCHENER H C, et al. Ovarian cancer[J]. Lancet,2014,384(9951):1376-1388.
14、 CHEN W, ZHENG R, BAADE P D, et al. Cancer statistics in China[J]. CA Cancer J Clin, 2016, 66(2): 115. CHEN W, ZHENG R, BAADE P D, et al. Cancer statistics in China[J]. CA Cancer J Clin, 2016, 66(2): 115.
上一篇
下一篇
出版者信息








《广州医药》公众号
目录